DEBx Medical is assured of a better investment by TVM Capital Healthcare

Beginning of the next phase of innovation in chronic time organization

DEBx Medical is an investor for a cut in spending on chronic conditions, which is being implemented by TVM Capital Healthcare’s second investment round.

AMSTERDAM and DUBAI, United Arab Emirate, November 13, 2024 (GLOBE NEWSWIRE) — DEBx Medical, an Amsterdam-based, innovative pioneer in the field of Fortschrittlichen Wundversorgung, gives the follow-up report about the future of Capital Investments Run under the Leitung von TVM Capital Healthcare confesses. Financing the global expansion of DEBx Medical in key markets around the world.

The investments that followed a thorough financing round and mirror the results in DEBx Medical’s innovative Ansatz in the management of long-term treatment are becoming broader, uninterrupted by the short-term release DEBRICHEM^®a current topic on the treatment of biofilm and infections in chronic injuries.

Global market expansion would extend the chronic history of the company

This second investment round is the strategy of external medicine, in the strong regulations and legislative intensive market developments that are expanding and the mission of DEBx Medical in the substructure, the management that is constantly concerned with care and the care of the patients who work.

Chronic problems pose a well-being problem to the health care system, no longer weighing to a large extent, but also weighing the best costs, complications, and treatment quality of the patient.

DEBRICHEM^® can be an undeniable problem with the full exposure to biofilm and infections in chronic injuries. With the CE and ISO certification that can address the market research results of the patients, attention is paid to it.

General perspective

“This new financing round from TVM Capital Healthcare is the well-known market research round from DEBRICHEM^® care and DEBx Medical in low healthcare, more patients will be there and never heal Wunden verursachte Leiden zu lindern“, so Tristan de BoyssonManaging Partner of TVM Capital Healthcare. “If we stop the strategy of the TVM Healthcare Afiyah Fund party, innovative solutions in the MENA region, in particular in the Saudi Arabian royal family, and a friend of the sisters with that end-druckenden team, one of those things that we to see.”

TVM Capital Healthcare’s serious investment with DEBx Medical in the low market, the market developments of which will be carried out later.

“We are happy to write on our way to the global Expansion of DEBx Medical,” so Bert QuintCEO of DEBx Medical. This round of financing is one of the most common problems in the world of goose business, while the charges take forever to come to fruition. The Unterstützung unserer Investors is a strong best option for the potential products, the Wundversorgung weltweit zu changen.”

Developing Innovation in the Wundversorgung

DEBRICHEM^® hat in Europe and in the region of the MENA region, a healthy environment in the KSA, great care and good medical care, and a healthy care solution. The product has an excellent reputation in protecting the world’s diseases, biofilm and infections from a problem.

An average snippet of this page is by clicking the links.

Künftiges Wachstum und Entwicklung

Neben der Ausweitung seiner special Reichweite plant DEBx Medical, seine Research and Entwicklungsbemühungen weiter voranzutreiben, a new Lösungen für de Wundversorgung einzuführen. The concept of internal medicine on clinical data and evidence can be meditated in a way that a kraft paper can be used, if it is a product portfolio that is expanded and the uncovered part of the treatment of the treatment on the deck.

Über DEBx Medical

DEBx Medical The fact is that it is funded by innovative, innovative sources of financing. Since 2019, it has been incurable that it is his concern that patients continue to deal with their illness for a long time, reimburses and cures personal bahnbrechende Hilfsmittel with an effective treatment complex that is developing into a stellt. DEBRICHEM^®The Vorzeigeproduct of the Unternehmens is a current topic, the biofilm and infections are safe and a fast and efficient Wundheilung source. Weitere Informationen finden Sie unter: DEBx Medical – Innovating the future of wound care (debx-medical.com)

Über TVM Capital Healthcare

TVM Capital Healthcare It is a prosperous company in the field of private equity companies in general, specializing in Schwellenländer hats. Das Unternehmen mit Hauptsitz in Dubai and Singapur and Niederlassungen in Riad, Boston, Munich and Ho-Chi-Minh-Stadt invests in Expansions- und Wachstumskapital in Unternehmen des Gesundheitswesens, a local local quality organization Anbieter von medizinische products in the Bereichen Pharma, Medizintechnik and Diagnostics. The Investitions- und Betriebspartner ensures a strong regional and international Gruppe that has developed a long history of investment in business and a umfahrung agent in Nahen Osten and in South Africa. For more information, please visit: TVMCapitalHealthcare.com

For the Medienanfragen you may have a bitte:

DEBx Medical: Chandrita Jaisinghani, (email protected)+31 85 0878096

Quelle Hugin